Granimax 1mg Injection
Marketer
Archicare Limited
Salt Composition
Granisetron (1mg)
Overview Granimax 1mg Injection
Emizone 1mg Injection, an antiemetic medication, effectively manages nausea and vomiting resulting from surgery, chemotherapy, or radiation therapy. However, it doesn't address other cancer treatment side effects. Administered by a healthcare provider, this injection should be used precisely as directed. Continuous use is crucial until medically discontinued, potentially transitioning to oral medication afterward. Common side effects – injection site discomfort, headache, bowel irregularities (constipation or diarrhea), and fatigue – typically resolve upon cessation. Persistent or bothersome symptoms warrant medical consultation for management strategies. Prior to treatment, disclose any pre-existing heart or liver conditions, gastrointestinal obstructions, and all other medications, particularly those for epilepsy, cardiac issues, cancer, or depression, as interactions are possible. Pregnant or breastfeeding individuals should seek medical guidance before use.
Uses of Granimax 1mg Injection
Chemotherapy-induced emesis
Major Benefits of Granimax 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Granimax 1mg Injection:
- Injection site pain
- Constipation
- Diarrhea
- Headache
- Weakness
- Insomnia (difficulty in sleeping)
How to use Granimax 1mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Granimax 1mg Injection works:
Granimax 1mg injection is an anti-vomiting drug. Its mechanism involves inhibiting serotonin, a neurotransmitter in the brain, thereby preventing chemotherapy-induced or post-surgical nausea and vomiting.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Granimax 1mg Injection may pose unknown risks. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
Granimax 1mg injections are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Granimax 1mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant exposure.
DrivingSAFE
Driving ability is typically unaffected by Granimax 1mg Injection.
KidneySAFE IF PRESCRIBED
The use of Granimax 1mg Injection in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Granimax 1mg Injection in patients with liver impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Granimax 1mg Injection :
Should you forget a Granimax 1mg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Granimax 1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Indazole-based compound |
| Developing Good Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | 5-HT3 receptor blockers |
3,018 People bought this recently